Delivery Order SPE2DR25D2104-SPE2DR26F3QRA
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This delivery order, valued at approximately $39,906, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count) in the amount of $1,908.41. The contract was awarded on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-competitive delivery order represents a firm fixed-price transaction under AmerisourceBergen's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180 count) with a ceiling value of $5,490.37. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 4, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count packages) valued at $3,508.43. This contract utilizes a firm fixed-price structure with an ultimate completion date of September 26, 2025, and was awarded on a competitive basis without any set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a contract ceiling value of $5,550.17. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) valued at $8,599.50. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at approximately $1 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $19,423.78. This firm fixed-price delivery order represents a non-set-aside, competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. The ultimate completion date for this delivery order is August 5,...
- The Defense Logistics Agency awarded a delivery order valued at $5,169.04 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (60-count units). The contract was competitively awarded without set-aside designation under a firm fixed-price structure, with an ultimate completion date of November 6, 2025. AmerisourceBergen's Conshohocken, Pennsylvania corporate office will serve as the place of performance for this order. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,241.42 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180 count) on November 12, 2025, with an ultimate completion date of November 13, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,238.40 to AmerisourceBergen Drug Corp for Janumet XR 50-1,000 mg tablets (180 count) on January 22, 2025, with completion scheduled for January 23, 2025. This firm fixed price delivery order, which carries no set-aside designation, was competitively awarded and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3QRADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count packages) with a ceiling value of $1,216.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a broad portfolio of medications and medical supplies to support Defense Health Agency operations and other government healthcare systems. The company's federal contracting demonstrates extensive experience fulfilling military pharmaceutical requirements through competitive delivery orders with firm fixed pricing across multiple therapeutic domains. This particular delivery order for Janumet XR, an oral antidiabetic medication, exemplifies the routine pharmaceutical supply missions executed under the company's DLA prime vendor contract, which enables flexible support for military medical supply chain needs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/3/25 |